Skip to main content
. 2014 Apr 17;7(6):613–623. doi: 10.1242/dmm.013904

Fig. 6.

Fig. 6.

GEMM Kras similarity score assigned within the PETACC-3 KRAS mutant population is associated with poor prognosis. (A–C) The PETACC-3 KRAS mutant population was treated separately and a similarity score was assigned to each KRAS mutant patient, based on similarity to the GEMM Kras signature. Kaplan-Meier curves demonstrating that the GEMM Kras signature is predictive of poor overall survival (OS, A), relapse-free survival (RFS, B), and survival after relapse (SAR, C) within the PETACC-3 KRAS mutant population. Survival times were cut at 84 months.